Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyltransferase.

BACKGROUND Carbohydrate-deficient transferrin (CDT) is used as a serum marker for heavy drinking. We compared a new Bio-Rad %CDT TIA assay with the CDTect assay; we also compared both to gamma-glutamyltransferase (GGT) as markers of heavy drinking. METHODS Serum samples of well-defined alcoholics (n = 404) and matched (age, race, and gender) social drinkers (204) from 10 clinical centers were assayed with both CDT assays. Both assays use microcolumn separation after iron saturation, followed by enzyme immunoassay (CDTect) or turbidimetric immunoassay (Bio-Rad %CDT). In the latter, CDT is expressed as a percentage of total transferrin. RESULTS The slope and intercept [95% confidence intervals (CIs)] for linear regression of results obtained by the %CDT-TIA (as percentage) and CDTect (units/L) assays were 0.091 (0.088-0.097) and 0.70% (0.54-0.86%), respectively (S(y/x) =1.30%; r = 0.848). The areas under the ROC curves (95% CIs) for CDTect and Bio-Rad %CDT TIA were 0.89 (0.86-0.92) and 0.88 (0.85-0.91), respectively, for men (P, not significant) and 0.76 (0.72-0.80) and 0.72 (0.68-0.76) for women (P, not significant). When CDT (CDTect or Bio-Rad %CDT) was combined with GGT (either one positive), the clinical sensitivity in men was 90% for both assays, and specificities were 81% and 84%, respectively; sensitivities in women were 75% and 76%, respectively, and specificities were 87% and 91%. CONCLUSION The new Bio-Rad %CDT TIA assay compares favorably to the widely studied CDTect assay in the detection of alcohol-use disorders.

[1]  J. Boeynaems,et al.  A Simple Method for Carbohydrate-Deficient Transferrin Measurement in Patients with Alcohol Abuse and Hepato-Gastrointestinal Diseases , 1998, Annals of clinical biochemistry.

[2]  D. Oslin,et al.  Clinical correlations with carbohydrate-deficient transferrin levels in women with alcoholism. , 1998, Alcoholism, clinical and experimental research.

[3]  O. Aasland,et al.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.

[4]  D. Bruns,et al.  Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. , 2000, Clinical chemistry.

[5]  R. Anton,et al.  The use of carbohydrate deficient transferrin as an indicator of alcohol consumption during treatment and follow-up. , 1996, Alcoholism, clinical and experimental research.

[6]  P Bean,et al.  Two methods for measuring carbohydrate-deficient transferrin in inpatient alcoholics and healthy controls compared. , 1994, Clinical chemistry.

[7]  P. Sillanaukee.  Laboratory markers of alcohol abuse. , 1996, Alcohol and alcoholism.

[8]  S. Borg,et al.  Detection of relapses in alcohol-dependent patients using carbohydrate-deficient transferrin: improvement with individualized reference levels during long-term monitoring. , 1995, Alcoholism, clinical and experimental research.

[9]  M. Sobell,et al.  Differences in baseline drinking behavior between alcoholics and normal drinkers. , 1972, Behaviour research and therapy.

[10]  M. Mattioli,et al.  Carbohydrate‐deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron , 1999 .

[11]  G. Meerkerk,et al.  The specificity of the CDT assay in general practice: the influence of common chronic diseases and medication on the serum CDT concentration. , 1998, Alcoholism, clinical and experimental research.

[12]  D. Simpson,et al.  Carbohydrate deficient transferrin in detecting relapse in alcohol dependence. , 1997, Drug and alcohol dependence.

[13]  P. Dufeu,et al.  Superiority of carbohydrate-deficient transferrin to gamma-glutamyltransferase in detecting relapse in alcoholism. , 1997, The American journal of psychiatry.

[14]  J. Allen,et al.  Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption. , 1995, Alcoholism, clinical and experimental research.

[15]  P. Bean,et al.  Semiautomated procedures for evaluation of carbohydrate-deficient transferrin in the diagnosis of alcohol abuse. , 1997, Clinical chemistry.

[16]  O. Niemelä,et al.  Comparison of the Axis %CDT TIA and the CDTect method as laboratory tests of alcohol abuse. , 1998, Clinical chemistry.

[17]  E. Haug,et al.  Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. , 1993, Alcoholism, clinical and experimental research.

[18]  M. Sterneck,et al.  Carbohydrate-deficient transferrin: diagnostic efficiency among patients with end-stage liver disease before and after liver transplantation. , 1998, Alcoholism, clinical and experimental research.

[19]  Carbohydrate‐deficient transferrin in the assessment of harmful alcohol consumption: diagnostic performance and clinical significance , 1999, Addiction biology.

[20]  R. Anton,et al.  Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study. , 2001, Alcoholism, clinical and experimental research.

[21]  R. Anton,et al.  Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. , 1994, Alcoholism, clinical and experimental research.

[22]  C. Allgulander,et al.  Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. , 2009, Acta medica Scandinavica.